Orginal Article |
|
|
|
|
Diagnostic Value of CD11c Antigen in Patients with Chronic Lymphocytic Leukemia |
ZHAO Si-shu,LIU Lu,LIU Fang,QIU Hai-rong,FAN Lei,LI Jian-yong,WU Yu-jie() |
The First Affiliated Hospital with Nanjing Medical University,Jiangsu Province Hospital,Hematology Department,Nanjing 210029,China |
|
|
Abstract Objective: To explore the expression of CD11c antigen in patients with chronic lymphocytic leukemia(CLL),and its clinical diagnostic value,as well as the correlation of CD11c with genetic abnormalities.Methods: 200 cases of CLL,49 cases of MCL were detected for CD11c expression rate and mean fluorescence intensity(MFI)by Multi parameter flow cytometry (FCM).And the relationship between CD11c expression and prognostic markers (ZAP-70 and CD38) expression in 200 CLL patients were compared.At the same time,the fluorescence in situ hybridization(FISH) was used to detecte P53 deletion, 13q14 deletion, ATM deletion, 6q23 deletion,+12 and IGH rearrangement.Then the genetic abnormalities were compared between CD11c - and CD11c + CLL patients. Results: The CD11c positive rate in CLL patients was 49.5%(99/200),MFI median 2.06(1.00 to7.34).While the CD11c positive rate in MCL patients was 6.12%(3/49).MFI median 2.00(1.97 to 2.54).The positive rate of CD11c expression were significantly higher in CLL patients than in MCL patients(x 2=30.62,P<0.05).The positive rate of ZAP-70 and CD38 were significantly higher in CD11c +CLL patients than CD11c -CLL patients(x 2=15.472,P<0.05;x 2=11.556,P<0.05). The results of P53 deletion, 13q14 deletion,ATM deletion,6q23 deletion,+12 and IGH rearrangement were all not significantly different between CD11c - and CD11c + CLL patients. Conclusion: CD11c has significant value for assistant diagnosis of CLL,especially for the differential diagnosis between CLL and MCL.
|
Received: 22 August 2019
Published: 20 September 2019
|
|
Corresponding Authors:
Yu-jie WU
E-mail: wuyujiel23456@163.com
|
|
|
[1] |
Takenaka S , McCormick S, Safroneeva E,et al.Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues. Clin Vaccine Immunol, 2009,16(11):1615-1623.
|
|
|
[2] |
Steven H S, Elias C. 《造血与淋巴组织肿瘤WHO分类》.第四版, 北京:诊断病理学杂志社, 2008: 365-492.
|
|
|
[2] |
Steven H S, Elias C . WHO classification of tumors of hematopoietic and lymphoid tissue.4 th Edition . Beijing:Chinese Journal of Diagnostic Pathology, 2008: 365-492.
|
|
|
[3] |
朱立华 . 高表达CD22/CD11c双阳性细胞群在诊断毛细胞白血病中的应用. 中华检验医学杂, 1997,20(2):106-108.
|
|
|
[3] |
Zhu L H . High expression of CD22/CD11c in the diagnosis of hairy cell leukemia. Chinese Journal of Laboratory Medicine, 1997,20(2):106-108.
|
|
|
[4] |
Hanson C A, Gribbin T E, Schnitzer B , et al. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood, 1990,76(11):2360-2367.
|
|
|
[5] |
Perkovic S, Basic-Kinda S, Aurer I , et al. Multiparameter flow cytometry is necessary for detection,characterization and diagnostics of composite mature B-cell lymphoproliferative neoplasms. Int J Hematol, 2013,98(5):589-596.
doi: 10.1007/s12185-013-1432-7
|
|
|
[6] |
Medd P G, Clark N, Leyden K , et al. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Cytometry B Clin Cytom, 2011,80(4):230-237.
|
|
|
[7] |
Julius M C, Robert E L, Rachel N W , et al. Zap-70 and CD38 as predictors of IgVH mutation in CLL. Experimental and Molecular Pathology, 2007,83(3):459-461.
doi: 10.1016/j.yexmp.2007.08.009
|
|
|
[8] |
徐卫, 李建勇, 潘金兰 , 等. 双色荧光原位杂交技术检测慢性淋巴细胞白血病IGH基因易位. 中华检验医学杂, 2006,29(8):711-713.
|
|
|
[8] |
Xu W, Li J Y, Pan J L , et al. Detection of IgH gene translocation in chronic lymphocytic leukemia by dual-color fluorescence in situ hybridization. Chinese Journal of Laboratory Medicine, 2006,29(8):711-713.
|
|
|
[9] |
Daniela L ,Martin J S D, Jose M G,et al. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. British Journal of Haematology, 1997,99(4):848-857.
|
|
|
[10] |
Michele D B ,Rossi F M,Rossi D, et al. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocyticleukemia, 2011,50(8):633-643.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|